Department of Medicine, University of Washington, Seattle, WA, United States of America.
Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America.
PLoS One. 2022 May 3;17(5):e0267729. doi: 10.1371/journal.pone.0267729. eCollection 2022.
Although immune activation is associated with HIV acquisition, the nature of inflammatory profiles that increase HIV risk, which may include responses to M. tuberculosis (Mtb) infection, are not well characterized.
We conducted a nested case-control study using cryopreserved samples from persons who did and did not acquire HIV during the multinational Step clinical trial of the MRKAd5 HIV-1 vaccine. PBMCs from the last HIV-negative sample from incident HIV cases and controls were stimulated with Mtb-specific antigens (ESAT-6/CFP-10) and analyzed by flow cytometry with intracellular cytokine staining and scored with COMPASS. We measured inflammatory profiles with five Correlates of TB Risk (CoR) transcriptomic signatures. Our primary analysis examined the association of latent Mtb infection (LTBI; IFNγ+CD4+ T cell frequency) or RISK6 CoR signature with HIV acquisition. Conditional logistic regression analyses, adjusted for known predictors of HIV acquisition, were employed to assess whether TB-associated immune markers were associated with HIV acquisition.
Among 465 participants, LTBI prevalence (21.5% controls vs 19.1% cases, p = 0.51) and the RISK6 signature were not higher in those who acquired HIV. In exploratory analyses, Mtb antigen-specific polyfunctional CD4+ T cell COMPASS scores (aOR 0.96, 95% CI 0.77, 1.20) were not higher in those who acquired HIV. Two CoR signatures, Sweeney3 (aOR 1.38 (1.07, 1.78) per SD change) and RESPONSE5 (0.78 (0.61, 0.98)), were associated with HIV acquisition. The transcriptomic pattern used to differentiate active vs latent TB (Sweeney3) was most strongly associated with acquiring HIV.
LTBI, Mtb polyfunctional antigen-specific CD4+ T cell activation, and RISK6 were not identified as risks for HIV acquisition. In exploratory transcriptomic analyses, two CoR signatures were associated with HIV risk after adjustment for known behavioral and clinical risk factors. We identified host gene expression signatures associated with HIV acquisition, but the observed effects are likely not mediated through Mtb infection.
尽管免疫激活与 HIV 感染有关,但增加 HIV 风险的炎症特征的性质尚不清楚,其中可能包括对结核分枝杆菌(Mtb)感染的反应。
我们使用来自多国 Step 临床试验中未感染 HIV 的人和感染 HIV 的人的冷冻保存样本进行了一项嵌套病例对照研究。从新发病例和对照者的最后一次 HIV 阴性样本中分离出 PBMC,用 Mtb 特异性抗原(ESAT-6/CFP-10)刺激,并用细胞内细胞因子染色进行流式细胞术分析,并通过 COMPASS 进行评分。我们使用五个结核风险相关因素(CoR)转录组学特征来测量炎症特征。我们的主要分析检查了潜伏性 Mtb 感染(LTBI;IFNγ+CD4+T 细胞频率)或 RISK6 CoR 特征与 HIV 感染的相关性。采用条件逻辑回归分析,调整已知的 HIV 感染预测因素,评估与结核相关的免疫标志物是否与 HIV 感染相关。
在 465 名参与者中,感染 HIV 的参与者的 LTBI 患病率(21.5%的对照组与 19.1%的病例组,p=0.51)和 RISK6 特征并不更高。在探索性分析中,感染 Mtb 抗原特异性多能性 CD4+T 细胞 COMPASS 评分(aOR 0.96,95%CI 0.77,1.20)在感染 HIV 的参与者中也没有更高。两个 CoR 特征,Sweeney3(aOR 1.38(1.07,1.78)每 SD 变化)和 RESPONSE5(0.78(0.61,0.98))与 HIV 感染有关。用于区分活动性和潜伏性结核病的转录组模式(Sweeney3)与感染 HIV 最密切相关。
LTBI、Mtb 多能性抗原特异性 CD4+T 细胞激活和 RISK6 未被确定为 HIV 感染的危险因素。在探索性转录组分析中,在调整已知的行为和临床危险因素后,两个 CoR 特征与 HIV 风险相关。我们确定了与 HIV 感染相关的宿主基因表达特征,但观察到的影响可能不是通过 Mtb 感染介导的。